Application 218347

Type
NDA
Sponsor
ABBVIE

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001RINVOQ LQUPADACITINIBSOLUTION;ORAL1MG/MLYesYes

Documents

DocumentSubmission typeDate
85995SUPPL 2026-05-21
85990SUPPL 2026-05-21
83759SUPPL 2025-10-15
83748SUPPL 2025-10-14
83747SUPPL 2025-10-14
81951ORIG 2025-04-11
81770SUPPL 2025-03-28
81752SUPPL 2025-03-27
81751SUPPL 2025-03-27
78299ORIG 2024-04-29
78289ORIG 2024-04-29